{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:57:33Z","timestamp":1740135453709,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0883-4","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T09:14:57Z","timestamp":1533028497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5243-8985","authenticated-orcid":false,"given":"Carsten","family":"Tsch\u00f6pe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Alogna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Spillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Faragli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunther","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Willner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Noutsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Krackhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"issue":"8","key":"883_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628\u201351.","journal-title":"J Card Fail"},{"issue":"8","key":"883_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891\u2013975.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"883_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jchf.2016.03.013","volume":"4","author":"C Tschope","year":"2016","unstructured":"Tschope C, Pieske B. \u201cOne Size Does Not Fit All\u201d: How to Individualize Decongestive Therapy Strategies in Heart Failure. JACC Heart failure. 2016;4(6):460\u20133.","journal-title":"JACC Heart failure"},{"issue":"3","key":"883_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ejim.2012.11.015","volume":"24","author":"M Mejhert","year":"2013","unstructured":"Mejhert M, Lindgren P, Schill O, Edner M, Persson H, Kahan T. Long term health care consumption and cost expenditure in systolic heart failure. Eur J Intern Med. 2013;24(3):260\u20135.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"883_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606\u201319.","journal-title":"Circ Heart Fail"},{"issue":"13","key":"883_CR6","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.107.696906","volume":"116","author":"SD Solomon","year":"2007","unstructured":"Solomon SD, Dobson J, Pocock S, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116(13):1482\u20137.","journal-title":"Circulation"},{"issue":"24","key":"883_CR7","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","volume":"363","author":"SI Chaudhry","year":"2010","unstructured":"Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in Patients with Heart Failure. N Engl J Med. 2010;363(24):2301\u20139.","journal-title":"N Engl J Med"},{"issue":"17","key":"883_CR8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.111.018473","volume":"123","author":"F Koehler","year":"2011","unstructured":"Koehler F, Winkler S, Schieber M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011;123(17):1873\u201380.","journal-title":"Circulation"},{"issue":"3","key":"883_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamainternmed.2015.7712","volume":"176","author":"MK Ong","year":"2016","unstructured":"Ong MK, Romano PS, Edgington S, et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med. 2016;176(3):310\u20138.","journal-title":"JAMA Intern Med"},{"issue":"9943","key":"883_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(14)61176-4","volume":"384","author":"G Hindricks","year":"2014","unstructured":"Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583\u201390.","journal-title":"Lancet"},{"issue":"1","key":"883_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.111.962969","volume":"5","author":"CE Angermann","year":"2012","unstructured":"Angermann CE, Stork S, Gelbrich G, et al. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail. 2012;5(1):25\u201335.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"883_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/archinternmed.2007.83","volume":"168","author":"T Jaarsma","year":"2008","unstructured":"Jaarsma T, van der Wal MH, Lesman-Leegte I, et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008;168(3):316\u201324.","journal-title":"Arch Intern Med"},{"issue":"41","key":"883_CR13","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1093\/eurheartj\/ehw099","volume":"37","author":"M Bohm","year":"2016","unstructured":"Bohm M, Drexler H, Oswald H, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J. 2016;37(41):3154\u201363.","journal-title":"Eur Heart J"},{"issue":"30","key":"883_CR14","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/eurheartj\/ehx227","volume":"38","author":"JM Morgan","year":"2017","unstructured":"Morgan JM, Kitt S, Gill J, et al. Remote management of heart failure using implantable electronic devices. Eur Heart J. 2017;38(30):2352\u201360.","journal-title":"Eur Heart J"},{"issue":"8","key":"883_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJMoa010641","volume":"345","author":"MH Drazner","year":"2001","unstructured":"Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345(8):574\u201381.","journal-title":"N Engl J Med"},{"issue":"2","key":"883_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ahj.2007.01.041","volume":"154","author":"S Setoguchi","year":"2007","unstructured":"Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154(2):260\u20136.","journal-title":"Am Heart J"},{"issue":"15","key":"883_CR17","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.jacc.2017.08.058","volume":"70","author":"L Klein","year":"2017","unstructured":"Klein L. (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure. J Am Coll Cardiol. 2017;70(15):1887\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"883_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11897-009-0039-z","volume":"6","author":"PB Adamson","year":"2009","unstructured":"Adamson PB. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep. 2009;6(4):287\u201392.","journal-title":"Curr Heart Fail Rep"},{"issue":"14","key":"883_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","volume":"118","author":"MR Zile","year":"2008","unstructured":"Zile MR, Bennett TD, St John Sutton M, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118(14):1433\u201341.","journal-title":"Circulation"},{"issue":"11","key":"883_CR20","first-page":"1073","volume":"51","author":"RC Bourge","year":"2008","unstructured":"Bourge RC, Abraham WT, Adamson PB, et al. Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure. The COMPASS-HF Study. 2008;51(11):1073\u20139.","journal-title":"The COMPASS-HF Study"},{"issue":"9766","key":"883_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","volume":"377","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658\u201366.","journal-title":"Lancet"},{"issue":"5","key":"883_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jchf.2015.11.011","volume":"4","author":"MR Costanzo","year":"2016","unstructured":"Costanzo MR, Stevenson LW, Adamson PB, et al. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring. JACC Heart Fail. 2016;4(5):333\u201344.","journal-title":"JACC Heart Fail"},{"doi-asserted-by":"crossref","unstructured":"Adamson PB, Abraham WT, Stevenson LW, et al. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions. Circ Heart Fail. 2016;9(6).","key":"883_CR23","DOI":"10.1161\/CIRCHEARTFAILURE.115.002600"},{"issue":"10017","key":"883_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","volume":"387","author":"WT Abraham","year":"2016","unstructured":"Abraham WT, Stevenson LW, Bourge RC, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet. 2016;387(10017):453\u201361.","journal-title":"Lancet"},{"issue":"15","key":"883_CR25","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.jacc.2017.08.010","volume":"70","author":"MM Givertz","year":"2017","unstructured":"Givertz MM, Stevenson LW, Costanzo MR, et al. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017;70(15):1875\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"883_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijcard.2016.05.009","volume":"218","author":"MS Nieminen","year":"2016","unstructured":"Nieminen MS, Buerke M, Cohen-Solal A, et al. The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion. Int J Cardiol. 2016;218:150\u20137.","journal-title":"Int J Cardiol"},{"key":"883_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2015.08.188","volume":"202","author":"S Silvetti","year":"2016","unstructured":"Silvetti S, Nieminen MS. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis. Int J Cardiol. 2016;202:138\u201343.","journal-title":"Int J Cardiol"},{"doi-asserted-by":"crossref","unstructured":"Altenberger J, Gustafsson F, Harjola VP, et al. Levosimendan in acute and advanced heart failure: an appraisal of the clinical database and evaluation of its therapeutic applications. J Cardiovasc Pharmacol. 2018;71(3):129\u2013136.","key":"883_CR28","DOI":"10.1097\/FJC.0000000000000533"},{"issue":"3","key":"883_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","volume":"11","author":"A Mebazaa","year":"2009","unstructured":"Mebazaa A, Nieminen MS, Filippatos GS, et al. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE. Eur J Heart Fail. 2009;11(3):304\u201311.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"883_CR30","first-page":"227","volume":"5","author":"MS Nieminen","year":"2013","unstructured":"Nieminen MS, Fruhwald S, Heunks LM, et al. Levosimendan: current data, clinical use and future development. Heart, lung and vessels. 2013;5(4):227\u201345.","journal-title":"Heart, lung and vessels"},{"issue":"4","key":"883_CR31","first-page":"276","volume":"76","author":"G Landoni","year":"2010","unstructured":"Landoni G, Mizzi A, Biondi-Zoccai G, et al. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol. 2010;76(4):276\u201386.","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"883_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.jvca.2009.05.031","volume":"24","author":"G Landoni","year":"2010","unstructured":"Landoni G, Mizzi A, Biondi-Zoccai G, et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010;24(1):51\u20137.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"883_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1590\/S0066-782X2010005000072","volume":"95","author":"RA Ribeiro","year":"2010","unstructured":"Ribeiro RA, Rohde LE, Polanczyk CA. Levosimendan in acute decompensated heart failure: systematic review and meta-analysis. Arq Bras Cardiol. 2010;95(2):230\u20137.","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"883_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","volume":"40","author":"G Landoni","year":"2012","unstructured":"Landoni G, Biondi-Zoccai G, Greco M, et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med. 2012;40(2):634\u201346.","journal-title":"Crit Care Med"},{"doi-asserted-by":"crossref","unstructured":"Koster G, Wetterslev J, Gluud C, Zijlstra JG, Scheeren TW, van der Horst IC, Keus F. Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2014;41(2):203\u201321.","key":"883_CR35","DOI":"10.1007\/s00134-014-3604-1"},{"issue":"3","key":"883_CR36","doi-asserted-by":"publisher","first-page":"R140","DOI":"10.1186\/cc10263","volume":"15","author":"R Maharaj","year":"2011","unstructured":"Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care. 2011;15(3):R140.","journal-title":"Crit Care"},{"issue":"11","key":"883_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993\u20131004.","journal-title":"N Engl J Med"},{"issue":"7","key":"883_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/ejhf.115","volume":"16","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, et al. Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Eur J Heart Fail. 2014;16(7):817\u201325.","journal-title":"Eur J Heart Fail"},{"doi-asserted-by":"publisher","unstructured":"Angermann CE, Assmus B, Anker SD, et al. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF). Clin Res Cardiol. 2018. \n                    https:\/\/doi.org\/10.1007\/s00392-018-1281-8\n                    \n                   [Epub ahead of print].","key":"883_CR39","DOI":"10.1007\/s00392-018-1281-8"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0883-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0883-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0883-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T19:05:44Z","timestamp":1564513544000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0883-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0883-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"27 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All treatments the patients received are considered standard care for their condition.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent form obtained from patients for the publication of all information contained in this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"155"}}